Your browser doesn't support javascript.
loading
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
Reich, K; Silverberg, J I; Papp, K A; Deleuran, M; Katoh, N; Strober, B; Beck, L A; de Bruin-Weller, M; Werfel, T; Zhang, F; Biswas, P; DiBonaventura, M D; Chan, G; Farooqui, S A; Kerkmann, U; Clibborn, C.
Afiliação
  • Reich K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Silverberg JI; Moonlake Immunotherapeutics AG, Zug, Switzerland.
  • Papp KA; The George Washington University School of Medicine & Health Sciences, Washington, DC, USA.
  • Deleuran M; Alliance Clinical Trials and Probity Medical Research, Waterloo, Ontario, Canada.
  • Katoh N; The University of Toronto, Toronto, Ontario, Canada.
  • Strober B; Aarhus University Hospital, Aarhus, Denmark.
  • Beck LA; Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • de Bruin-Weller M; Yale University, New Haven, Connecticut, USA.
  • Werfel T; Central Connecticut Dermatology Research, Cromwell, Connecticut, USA.
  • Zhang F; University of Rochester Medical Center, Rochester, New York, USA.
  • Biswas P; UMC Utrecht, Utrecht, The Netherlands.
  • DiBonaventura MD; Hannover Medical School, Hannover, Germany.
  • Chan G; Pfizer Inc., Groton, Connecticut, USA.
  • Farooqui SA; Pfizer Inc., New York City, New York, USA.
  • Kerkmann U; Pfizer Inc., New York City, New York, USA.
  • Clibborn C; Pfizer Inc., Groton, Connecticut, USA.
J Eur Acad Dermatol Venereol ; 37(10): 2047-2055, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37319109
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2023 Tipo de documento: Article